The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after? DOI Creative Commons
Martina Gabrielli, Stefano Raffaele, Marta Fumagalli

и другие.

Frontiers in Cellular Neuroscience, Год журнала: 2022, Номер 16

Опубликована: Сен. 13, 2022

As resident component of the innate immunity in central nervous system (CNS), microglia are key players pathology. However, they also exert fundamental roles brain development and homeostasis maintenance. They extremely sensitive plastic, as assiduously monitor environment, adapting their function response to stimuli. On consequence, may be defined a heterogeneous community cells dynamic equilibrium. Extracellular vesicles (EVs) released by mirror nature donor cells, exerting important versatile functions CNS unbounded conveyors bioactive signals. In this review, we summarize current knowledge on EVs microglia, highlighting properties multifaceted effects.

Язык: Английский

Extracellular vesicle-mediated trafficking of molecular cues during human brain development DOI Creative Commons
Andrea Carolina Pérez Forero, Fabrizia Pipicelli, Sylvain Moser

и другие.

Cell Reports, Год журнала: 2024, Номер 43(10), С. 114755 - 114755

Опубликована: Сен. 19, 2024

Язык: Английский

Процитировано

8

Neuron‐derived extracellular vesicles as a liquid biopsy for brain insulin dysregulation in Alzheimer's disease and related disorders DOI Creative Commons

Jacob Cleary,

Ashish Kumar, Suzanne Craft

и другие.

Alzheimer s & Dementia, Год журнала: 2025, Номер unknown

Опубликована: Янв. 17, 2025

Extracellular vesicles (EVs) have emerged as novel blood-based biomarkers for various pathologies. The development of methods to enrich cell-specific EVs from biofluids has enabled us monitor difficult-to-access organs, such the brain, in real time without disrupting their function, thus serving liquid biopsy. Burgeoning evidence indicates that contents neuron-derived (NDEs) blood reveal dynamic alterations occur during neurodegenerative pathogenesis, including Alzheimer's disease (AD), reflecting a disease-specific molecular signature. Among these AD-specific changes is brain insulin-signaling dysregulation, which cannot be assessed clinically living patient and remains an unexplained co-occurrence AD pathogenesis. This review focused on delineating how NDEs may begin close gap between identifying associated with insulin dysregulation reliably patients its connection AD. approach could lead identification early less-invasive diagnostic HIGHLIGHTS: Neuron-derived extracellular isolated peripheral blood. reflect signature (AD). Brain plays critical role predict dysregulation. offer

Язык: Английский

Процитировано

1

Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review DOI Creative Commons

Radhakrishna Reddi Sree,

Manjunath Kalyan,

Nikhilesh Anand

и другие.

ACS Omega, Год журнала: 2025, Номер 10(6), С. 5148 - 5171

Опубликована: Фев. 3, 2025

Alzheimer's disease (AD) is an aging-related irreversible neurodegenerative affecting mostly the elderly population. The main pathological features of AD are extracellular Aβ plaques generated by APP cleavage through amyloidogenic pathway, intracellular neurofibrillary tangles (NFT) resulting from hyperphosphorylated tau proteins, and cholinergic neurodegeneration. However, actual causes unknown, but several studies suggest hereditary mutations in PSEN1 -2, APOE4, APP, TAU genes major perpetrators. In order to understand etiology pathogenesis AD, various hypotheses proposed. These include following hypotheses: amyloid accumulation, tauopathy, inflammation, oxidative stress, mitochondrial dysfunction, glutamate/excitotoxicity, deficiency, gut dysbiosis. Currently approved therapeutic interventions donepezil, galantamine, rivastigmine, which cholinesterase inhibitors (ChEIs), memantine, N-methyl-d-aspartate (NMDA) antagonist. treatment strategies focus on only symptomatic management attenuating symptoms not regeneration neurons or clearance Tau. This review focuses pathophysiology, novel targets, disease-altering treatments such as α-secretase modulators, active immunotherapy, passive natural antioxidant products, nanomaterials, antiamyloid therapy, aggregation inhibitors, transplantation fecal microbiota stem cells, microtubule stabilizers that clinical trials still under investigation.

Язык: Английский

Процитировано

1

Extracellular vesicles: translational research and applications in neurology DOI
Apostolos Manolopoulos, Pamela J. Yao, Dimitrios Kapogiannis

и другие.

Nature Reviews Neurology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 3, 2025

Язык: Английский

Процитировано

1

The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after? DOI Creative Commons
Martina Gabrielli, Stefano Raffaele, Marta Fumagalli

и другие.

Frontiers in Cellular Neuroscience, Год журнала: 2022, Номер 16

Опубликована: Сен. 13, 2022

As resident component of the innate immunity in central nervous system (CNS), microglia are key players pathology. However, they also exert fundamental roles brain development and homeostasis maintenance. They extremely sensitive plastic, as assiduously monitor environment, adapting their function response to stimuli. On consequence, may be defined a heterogeneous community cells dynamic equilibrium. Extracellular vesicles (EVs) released by mirror nature donor cells, exerting important versatile functions CNS unbounded conveyors bioactive signals. In this review, we summarize current knowledge on EVs microglia, highlighting properties multifaceted effects.

Язык: Английский

Процитировано

28